Fundamental Analysis
A Quandary for Those Who Went to Cash
The complete lack of enthusiasm from both equity buyers and option traders bodes very well for a continued market rally rather than yet another retest of the lows.
Is It Time to Bet on Biotech?
The government is turning on the flow of money to biotech at a time when the Fed is reducing the flow of money to the economy.
Carnival Is Still a Long Way From Home
This is not yet your pre-pandemic cruise line. The trip for CCL stockholders won't be an easy one.
Bad News Is Good News Again, But Good News Is Just Plain Good for Some Stocks
With supply-chain pressures receding and insiders buying, I added to my holdings in a small-cap name.
The Market's Q4 Start Should Not Be Surprising
When everybody is thinking negative... who is left to sell?
Oil: A Big Picture Review Ahead of the OPEC Meeting
While the cartel is attempting to prop prices up, they are working against seasonal tendencies.
A Trade on a Stock You Might Not Even Know Exists
Despite fine metrics, this year's crazy selloff has pushed the shares down to one of its lowest valuations ever.
Apple: Heavily Scrutinized, Yet Still Underestimated
Apple is a battleground and go-to stock all wrapped up in one..
The Bad News and the Good News Heading Into Q4 2022
Get ready for what should be a tremendous recovery as we progress through the strongest three months of the calendar based on decades of stock market history.
3 Dividend Stocks That Deliver High-Quality 'Returns'
ROIC is a valuable financial metric that can help identify the highest-quality stocks in the investing universe.